Endokrinologija

Zavod za endokrinologiju
Klinike za unutrašnje bolesti
Medicinskog fakulteta Sveučilišta u Zagrebu
KBC Zagreb, Rebro

Kišpatićeva 12
TEL 01 2376 581 / FAX 01 2376 036
E-MAIL endokrinologija@kbc-zagreb.hr

Ikona sekcije

Publikacije

1. Kaštelan D, Dušek T, Kraljević I, Aganović I. Hypercoagulable state in Cushing's syndrome is reversible following remission. Clin Endocrinol (Oxf). 2013; 78(1):102-6.

2. Dušek T, Melada A, Paladino J, Kaštelan D. Transsphenoidal surgery for pituitary adenoma: indications and outcomes. Croat Med J. 2012;53:639-41.

3. Dušek T, Kaštelan D, Melada A, Baretić M, Š koric Polovina T, Perković Z, Giljević Z, Jelčić J, Paladino J, Aganović I, Koršić M. Clinical features and therapeutic outcomes of patients with acromegaly: single centre experience. J Endocrinol Invest. 2011;34(11):e382-5.

4. Kaštelan D, Džubur F, Dušek T, Poljičanin T, Crnčević-Orlic Z, Kraljević I, Solak M, Benčevic T, Aganović I, Knežević N, Kaštelan Z, Koršić M. Health-related quality of life and fatigue in patients with adrenal incidentaloma. Endocrine. 2011 Aug;40(1):84-9.

5. Vlak T, Kaštelan D, Lozo P, Aljinović J, Gradišer M, Mijić S, Nikolić T, Miškić B, Car D, Tajšić G, Dušek T, Jajić Z, Grubišić F, Poljičanin T, Bakula M, Džubur F, Strižak-Ujević M, Kadojić M, Radman M, Vugrinec M, Kuster Z, Pekez M, Radović E, Labar L, Crnčević-Orlić Z, Koršić M. Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia. Clin Rheumatol 2011;30:1549-54.

6. Gornik I, Vujaklija-Brajković A, Renar IP, Gašparović V. A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes. Crit Care. 2010;14(4):R130. Erratum in: Crit Care. 2010;14(5):444.

7. Kaštelan D, Vlak T, Lozo P, Gradišer M, Mijić S, Nikolić T, Miškić B, Car D, Tajsić G, Dušek T, Jajić Z, Grubišić F, Poljičanin T, Bakula M, Džubur F, Strizak-Ujević M, Kadojić M, Radman M, Vugrinec M, Kušter Z, Pekez M, Radović E, Labar L, Crnčević-Orlić Z, Koršić M. Health-related quality of life among patients with postmenopausal osteoporosis treated with weekly and monthly bisphosphonates. Endocr Res 2010;35:165-73.

8. Kaštelan D, Koršić M, Kraljević I, Dušek T, Giljević Z, Koršić M. Low Serum 25-hydroxyvitamin D concentrations in healthy young males. J Endocrinol Invest. 2009;32(6):562-3.

9. Kaštelan D, Dušek T, Kraljević I, Polašek O, Giljević Z, Solak M, Š alek SZ, Jelčić J, Aganović I, Koršić M. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine. 2009;36(1):70-4.

10. Kaštelan D, Grubić Z, Kraljević I, Polašek O, Dušek T, Štingl K, Kerhin-Brkljačić V, Koršić M. The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab. 2009;27(2):198-204.

11. Dušek T, Kaštelan D, Solak M, Bašić Kinda S, Aganović I, Koršić M. Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest. 2008;31(10):940.

12. Kaštelan D, Koršić M, Vlak T. Ibandronate: is there an effect on nonvertebral fractures? Clin Rheumatol. 2008;27(10):1313-5.

13. Kaštelan D, Grubić Z, Kraljević I, Durić K, Kardum I, Dušek T, Š tingl K, Giljević Z, Kerhin-Brkljačić V, Suchanek E, Koršić M. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study. J Endocrinol Invest. 2007;30(6):465-9.

14. Kaštelan D, Dušek T, Kraljević I, Polašek O, Perković Z, Kardum I, Giljević Z, Jelčić J, Aganović I, Koršić M. Bone properties in patients with acromegaly: quantitative ultrasound of the heel. J Clin Densitom. 2007;10(3):327-31.

15. Turk N, Kaštelan D, Čukovic-Čavka S, Kraljević I, Koršić M, Vucelić B. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease. Ultrasound Med Biol. 2007;33(6):863-9.

16. Kaštelan D, Kujundžić-Tiljak M, Kraljević I, Kardum I, Giljević Z, Koršić M. Calcaneus ultrasound in males: normative data in the Croatian population (ECUM study). J Endocrinol Invest. 2006;29(3):221-5.

17. Dušek T, Koršić M, Koehler K, Perković Z, Huebner A, Koršić M. A novel AAAS gene mutation (p.R194X) in a patient with triple A syndrome. Horm Res. 2006;65(4):171-6.

18. Kaštelan D, Dušek T, Vizner B, Gnjidić Z, Orlić ZC, Kušec V, Heinrich Z, Vrkljan M, Koršić M; Croatian Society of Endocrinology guidelines for the diagnosis and treatment of acromegaly. Lijec Vjesn. 2012;134(3-4):65-8.

19. Kaštelan D, Dušek T, Aganović I, Š tern-Padovan R, Kuzmanić D, Kaštelan Z, Knežević N, Crnčević- Orlić Z, Kraljević I, Džubur F, Pavlić-Renar I, Giljević Z, Jelcić J, Baretić M, Š korić T, Koršić M. Management of adrenal incidentaloma: the position statement of the Croatian referral center for adrenal gland disorders]. Lijec Vjesn. 2010;132(3-4):71-5.

20. Jelčić J, Baretić M, Koršić M; Fourth Croatian Congress on Obesity. [4th guidelines on diagnosis and treatment of obesity]. Lijec Vjesn. 2010;132(9-10):269-71.